Get the SPI Wire

CNS Pharmaceuticals, Inc.

NASDAQ:CNSP
Annual Meeting

of Shareholders

MEETING DATE

09/30/2026
DEF 14A FILED
08/21/2026
PUBLISHED
08/21/2026 9:15 pm
TIME TO PUBLISH
08/23/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:CNSP · CUSIP 18978H508 · CLASS common stock · CIK 0001729427

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

4
FOR
1
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect six Board nominees to the Board of Directors of the Company, each to serve until the 2027 annual meeting of stockholders of the Company or until such person’s successor is qualified and elected.
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states all six nominees consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To ratify the appointment of MaloneBailey, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026.
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The audit committee selected MaloneBailey LLP and pre-approves all audit and non-audit services.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To vote on a non-binding, advisory resolution to approve executive compensation.
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states this advisory vote covers the executive compensation disclosed in the proxy statement.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve amendments to the Company’s 2020 Stock Plan including an increase in the number of shares of common stock authorized for issuance by 650,000 shares under the Company’s 2020 Stock Plan.
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states only 38,204 shares remained available for grant under the 2020 Plan.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To authorize the adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting or adjournment or postponement thereof to approve any of the above proposals.
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states adjournment could occur despite enough votes to defeat proposals to seek changed votes in favor.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

c94127adadc0aaeb2db0eefeb169b3145c9f8afc468a19184883ff53c44b7134

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates